Sharing outcomes

To further translate the substantial investment in scientific facilities into new quality productive forces, experts have highlighted the significance of information sharing, collaborative mechanisms, and the industrialization of experimental results.

Zhang says that while the CSNS has invested significant resources in tackling the specific challenges of companies from across industries, competition and insufficient communication have impeded the sharing of technological outcomes.

He hopes that the government or industry associations can serve as a bridge, enabling solutions provided by the CSNS to benefit more enterprises and accelerate industrial development.

Instead of waiting to serve the enterprises' demands, the institution will enhance its outreach to enterprises and adopt a more proactive approach to guide them through the use of this advanced scientific platform.

Looking forward to closer collaboration among scientific facilities, Huang says that many facilities require computing power for data analysis. Deeper cooperation could facilitate data transfer, providing enterprises with a one-stop service, he adds.

Prioritizing the enhancement of service capacity amid booming demands, Huang says that the center aims to secure stable and compatible domestic chips to address the international chip embargo, expand interdisciplinary talent, and further increase computing and storage capacity.

With a similar goal, the Shenzhen Synthetic Biology Infrastructure aims to leverage AI and national pilot platforms to support product design and testing. It will also engage in international standard-setting to boost the global competitiveness of domestic industries.

Liu Zhigang, head of the oncology department at Dongguan People's Hospital, which is conducting the BNCT clinical trial, says advanced scientific facilities in the Greater Bay Area have different strengths in disease treatment. There is significant potential to create integrated treatment plans, promoting regional development of the healthcare industry.

In his view, to promote the applications of large scientific facilities' outcomes, such as BNCT, the efficacy and versatility of therapies, cost and scale of devices, establishment of industrial chains, and support from health insurance are all crucial factors.

In Zhang's words, serving the industry has always been a mission of major scientific and technological infrastructure. As enterprises have become the main drivers of the nation's technological innovation, it is time for these facilities to get closer to them in order to turbocharge industrial upgrading.